Dr. Hugh A. “Chip” McAllister Jr. of Houston has made a $10 million commitment to the University of North Carolina at Chapel Hill that will include a collection of nearly 50 works of art for the Ackland Art Museum and expand an endowment dedicated to heart disease research at the School of Medicine.
UNC Cardiovascular Medicine and the American Heart Association gather to celebrate their 40-year partnership with a tour of UNC’s research facilities
Beginning in March 2012, Duke and UNC faculty will take the editorial helm of the Journal of Clinical Investigation (JCI).
Congratulations to A. Phil Owens, III, PhD, a post-doctoral trainee in the Mackman lab at the UNC McAllister Heart Institute. With this award, Dr. Owens will have support to transition from a mentored research environment with Dr. Nigel Mackman to an independent laboratory setting. Dr. Owens’ research focuses on abdominal aortic aneurysm (AAA) and the role of coagulation and platelets in protecting AAA from ruptures.
Nigel Key, MD and Nigel Mackman, PhD, have received a five-year, $1,986,650 grant to study the mechanisms of venous thromboembolism in cancer.
A study led by researchers from the University of North Carolina at Chapel Hill School of Medicine has identified a molecular pathway that leads to the formation of abnormal blood clots. They turned it off using a popular class of cholesterol-lowering drugs, statins.
Jianguo Wang, a member of the UNC McAllister Heart Institute, was one of the winners for his article entitled, "Levels of microparticle tissue factor activity correlate with coagulation activation in endotoxemic mice."
Nigel Mackman, Ph.D., will deliver the Sol Sherry Distinguished Lecture in Thrombosis at the 2009 American Heart Association’s (AHA) Scientific Sessions in November.
The School of Medicine is pleased to announce the appointment of Nigel Mackman, PhD, FAHA, as the new Director of the UNC McAllister Heart Institute (MHI).
UNC researchers receive $8.2-million grant to study the role of coagulation in pathology of sickle cell disease
A multi-disciplinary team of basic and clinical scientists from the Division of Hematology/Oncology in the Department of Medicine has received a five-year, $8.2-million grant from the NIH-NHLBI to study the role of coagulation in the pathology of sickle cell disease. Kenneth Ataga, MD, Nigel Key, MB, ChB, Nigel Mackman, PhD, and Rafal Pawlinski, PhD, will serve as co-PIs on the grant.
Nigel Mackman, PhD, John Parker Distinguished Professor of Hematology/Oncology and Director of the McAllister Heart Institute, was awarded a $1.5-million, four-year grant from the NIH-NHLBI to study the role of the thrombin-PAR1 pathway in viral infection.
Nigel Mackman, PhD, FAHA, is the John Parker Distinguished Professor of Medicine in the Division of Hematology/Oncology. He is also Associate Director of the UNC McAllister Heart Institute. He will give the honorary lecture at the 2011 Spring Arteriosclerosis, Thrombosis and Vascular Biology meeting in April.
A study by the Mackman Lab at the University of North Carolina uncovers some potential dangers for users of the blood thinner Pradaxa™.
Dr Nigel Mackman directs the UNC McAllister Heart Institute. In an engaging interview, he describes some of the seminal findings he has made in his 25-year career through explorations of the role of tissue factor in blood clotting in health and disease.
Researchers from the Mackman laboratory at the University of North Carolina at Chapel Hill are studying an essential gene in search of new and better anticoagulant therapies to reduce the incidence of vein thrombosis